Vimarsana
Biggest News Aggregation in the World

Claris Life Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Claris Life Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Claris Life Sciences Today - Breaking & Trending Today

Anti-infectives Market Size, Trends and Future Scope Forecast 2023-2033 - Vimarsana News

Anti-infectives Market Size, Trends and Future Scope Forecast 2023-2033

Anti-infectives Market: by Product (Antibiotics, Antivirals, Antifungals, Others), by Indication (HIV Infection, Pneumonia, Respiratory Virus Infection, Sepsis, Tuberculosis, Others), by Route Of Administration (Oral, Topical, Parenteral, Others), by

Anti-infectives Market to Witness Rise in Revenues By 2033 - Vimarsana News

Anti-infectives Market to Witness Rise in Revenues By 2033

Anti-infectives Market: by Product (Antibiotics, Antivirals, Antifungals, Others), by Indication (HIV Infection, Pneumonia, Respiratory Virus Infection, Sepsis, Tuberculosis, Others), by Route Of Administration (Oral, Topical, Parenteral, Others), by

India Business Roadshow in Cebu: A Potential for Partnership - Vimarsana News

India Business Roadshow in Cebu: A Potential for Partnership

THIRTY Indian businesses are expected to come to Cebu in November for a two-day business roadshow that aims to grow trade relations between India and Cebu. The upcoming business roadshow will focus on areas of agriculture, energy, infrastructure, innovative technology solutions, information technology-business process management, healthcare and pharmaceuticals, and tourism. This event will provide opportunities for trade and investments as well as generate awareness of the successes of Indian businesses. India and the Philippines registered a trade volume in surplus of US$3 billion last year. ...

Motilal Oswal buys 12-storey tower in Ahmedabad from Claris Life Sciences, ET RealEstate - Vimarsana News

Motilal Oswal buys 12-storey tower in Ahmedabad from Claris Life Sciences, ET RealEstate

The property spread over 0.56 acres will house Motilal Oswal Tower, which is the company's third such property after its independent commercial towers in Mumbai and Bengaluru.

Motilal Oswal buys 12-storey tower in Ahmedabad from Claris Life Sciences - Vimarsana News

Motilal Oswal buys 12-storey tower in Ahmedabad from Claris Life Sciences

Motilal Oswal Financial Services (MOFSL) has acquired a commercial tower in Ahmedabad to support its growth and expansion plans. The property, spread over 1,10,000 sq ft, will be the company's third standalone tower and will house its corporate office. MOFSL plans to complete the project by September 2024 and expects it to accommodate 650 employees.